ABOUT BLOCK PAIN RECEPTORS WITH PROLEVIATE

Owning recognized the palmitoylation motif of APLNR, we developed a brief substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation website together with morphine, can inhibit the event of NCP, together with pain incidence, microglial activation, and inflamma